Golfers raise funds for prostate cancer research

The John H. Kauffman Prostate Cancer Fundraiser, hosted annually by the Dunwoody Country Club's Champions Golf Association, raised $400,000 at its 2021 event. The community tournament, started in 2010, has raised more than $1 million in support of prostate cancer research at Winship Cancer Institute, including the Winship Invest$ Prostate Cancer Research Pilot Grant Program.

Mo receives NCI R37 award

Xiulei Mo, PhD, has received a National Cancer Institute Method to Extend Research in Time (MERIT) Award to discover novel chemical probes for targeted therapy in colorectal cancer. Co-investigators on the six-year grant include Yuhong Du, PhD, Andrey Ivanov, PhD, Jae Chang, PhD, and Haian Fu, PhD.

View in NIH RePORTER

Shah honored by Society of Asian Academic Surgeons

Mihir M. Shah, MD, has received a 2022 Junior Faculty Award from the Society of Asian Academic Surgeons. The award includes a travel grant to attend the Surgical Investigators’ Course at the Academic Surgical Congress and a two-year appointment to the Scholarships Committee.

About the Society

Winship’s Rockin’ Enrollers

Winship is committed to accelerating the testing of new cancer treatments through clinical research. Winship recognizes the following physicians at each Winship study site who have enrolled the most patients onto interventional cancer clinical trials during the last six months (pictured clockwise from top left): Pretesh Patel, MD, and Bree Eaton, MD (Emory Proton Therapy Center); Sheela Hanasoge, MBBS, PhD (Grady); Nabil Saba, MD (Midtown); Mehmet Bilen, MD (Clifton); Omer Kucuk, MD (Emory Saint Joseph's Hospital).

About Winship Clinical Trials

Winship investigators to lead Cutaneous and Uveal Malignancy Retreat

More than a dozen Winship investigators will present at the Cutaneous and Uveal Malignancy Retreat on Jan. 28 from 9 a.m. to 4:30 p.m. Sessions will focus on the program's clinical vision, unmet needs in the field, disparities, and the development of SPORE and team science grants.

Learn More

Emory Proton Therapy Center launches new website

The Emory Proton Therapy Center has launched a new website. The site provides in-depth information on use of this advanced technology as part of a complete, personalized treatment plan for various cancers. Patients and caregivers can learn about Winship's treatment team and state-of-the art facilities, take a virtual tour of the center, and request a consultation.

Visit Website

Call for applications: Footsteps to Funding virtual workshop

Sponsored by the Geographical Management of Cancer Health Disparities Program (GMaP) Region 2, Footsteps to Funding is an interactive virtual training workshop for trainees and early-stage investigators that provides guidance and support for the successful preparation of career development grant funding proposals. Applications are due Feb. 18.

Learn More

Call for proposals: Predoctoral fellowship in health outcomes research

The PhRMA Foundation's predoctoral fellowship award provides $25,000 per year in stipend support to promising students (U.S. and non-U.S. citizens) during advanced stages of training and thesis research and for the career development of scientists prepared to engage in health outcomes research. Applications are due Feb. 10.

Learn More

Below are four selected Winship publications out of 46 published over the past week:

Orellana-Noia VM, Reed DR, McCook AA, Sen JM, Barlow CM, Malecek MK, Watkins M, Kahl BS, Spinner MA, Advani R, Voorhees TJ, Snow A, Grover NS, Ayers A, Romancik J, Liu Y, Huntington SF, Chavez JC, Saeed H, Lazaryan A, Raghunathan V, Spurgeon SE, Ollila TA, Del Prete C, Olszewski A, Ayers EC, Landsburg DJ, Echalier B, Lee J, Kamdar M, Caimi PF, Fu T, Liu J, David KA, Alharthy H, Law J, Karmali R, Shah H, Stephens DM, Major A, Rojek AE, Smith SM, Yellala A, Kallam A, Nakhoda S, Khan N, Sohail MA, Hill BT, Barrett-Campbell O, Lansigan F, Switchenko J, Cohen J, Portell CA. Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions. Blood. 2022; 139(3):413-423. PubMed PMID: 34570876.

View in PubMed

Lozano AX, Chaudhuri AA, Nene A, Bacchiocchi A, Earland N, Vesely MD, Usmani A, Turner BE, Steen CB, Luca BA, Badri T, Gulati GS, Vahid MR, Khameneh F, Harris PK, Chen DY, Dhodapkar K, Sznol M, Halaban R, Newman AM. T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma. Nature Medicine. 2022; PubMed PMID: 35027754.

View in PubMed

Pollyea DA, DiNardo CD, Arellano ML, Pigneux A, Fiedler W, Konopleva M, Rizzieri DA, Smith BD, Shinagawa A, Lemoli RM, Dail M, Duan Y, Chyla B, Potluri J, Miller CL, Kantarjian HM. Impact of Venetoclax and Azacitidine in Treatment-Naive Patients with Acute Myeloid Leukemia and IDH1/2 mutations. Clinical Cancer Research: an official journal of the American Association for Cancer Research. 2022; PubMed PMID: 35046058.

View in PubMed

Tang KC, Cao J, Boatner LM, Li L, Farhi J, Houk KN, Spangle J, Backus KM, Raj M. Tunable Amine-Reactive Electrophiles for Selective Profiling of Lysine. Angewandte Chemie (International ed. in English). 2022; 61(5):e202112107. PubMed PMID: 34762358.

View in PubMed